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Abstract 
Background: Opioid addiction and overdose deaths are growing problems in both Sweden 
and the United States. Opioids have played a major role in anesthesia since the 1960s, but 
cause numerous negative effects which are associated with patient suffering and increased 
cost of care. Evidence shows opioid-free anesthesia is emerging as a safe alternative, reducing 
the negative effects of opioids. Research on the nurse anesthetists’ experiences of opioid-free 
anesthesia is limited. Aim: The aim of this study was to compare experiences among nurse 
anesthetists in Sweden and the United States with regards to their familiarity with opioid-free 
anesthesia, its perioperative risks and benefits, and the perceived connection between 
intraoperative opioids and postoperative addiction. Methods: A web-based survey was 
distributed to nurse anesthetists in Sweden and the United States. Data was analyzed using 
SPSS Statistics and presented descriptively, allowing comparisons between Sweden and the 
United States by displaying the data from the two nations in the same charts. Results: The 
nurse anesthetists from the United States had more experience with opioid-free anesthesia 
than the nurse anesthetists from Sweden. The majority of the nurse anesthetists from the 
United States agreed to all the benefits and disagreed to all the risks of opioid-free anesthesia 
listed in the survey. Many of the Swedish nurse anesthetists did not know the specific benefits 
and risks, nor which drugs should be included in an opioid-free anesthesia regime of care. 
Opioid addiction was perceived as a major problem in society by nurse anesthetists from both 
nations. Conclusion: American nurse anesthetists have more clinical experience and 
theoretical knowledge of opioid-free anesthesia compared to Swedish nurse anesthetists. 
More education is needed in Sweden to safely implement the concept. This study suggests 
that opioid-free anesthesia would be beneficial to Swedish nurse anesthetists’ nursing 
priorities and postoperative patient outcome. 
 
Keywords: Opioid-free anesthesia, OFA, General anesthesia, Non-opioid analgesics, Nurse 
anesthetist, Experience  
  
 
Sammanfattning 
Bakgrund: Opioidberoende och överdosrelaterade dödsfall är ett växande problem i både 
Sverige och USA. Opioider har haft en viktig roll inom anestesin sedan 1960-talet, men 
orsakar flera negativa effekter som kan leda till lidande för patienten och ökade vårdkostnader 
för samhället. I evidensbaserad forskning framträder opioidfri anestesi som ett patientsäkert 
alternativ som minskar de negativa effekterna av opioider. Forskningen på 
anestesisjuksköterskans upplevelse av opioidfri anestesi är begränsad. Syfte: Syftet med 
denna studie var att jämföra upplevelser och erfarenheter mellan anestesisjuksköterskor i 
Sverige och USA av förtrogenheten med opioidfri anestesi, dess perioperativa risker och 
fördelar, samt uppfattningen av ett samband mellan intraoperativa opioider och postoperativt 
beroende. Metod: En webbaserad enkät skickades ut till anestesisjuksköterskor i Sverige och 
USA. Data analyserades i SPSS Statistics och presenterades deskriptivt. Jämförelserna mellan 
Sverige och USA möjliggjordes genom att visa data från de två länderna tillsammans i samma 
diagram. Resultat: Anestesisjuksköterskorna i USA hade större erfarenhet av opioidfri 
anestesi än anestesisjuksköterskorna i Sverige. Majoriteten av anestesisjuksköterskorna i USA 
instämde med alla fördelar och instämde inte med alla risker med opioidfri anestesi som 
angavs i enkäten. Många av de svenska anestesisjuksköterskorna kände inte till de specifika 
fördelar och risker som angavs i enkäten, eller vilka läkemedel som borde inkluderas i en 
vårdplan för opioidfri anestesi. Anestesisjuksköterskor från båda länder ansåg att 
opioidberoende är ett stort problem i samhället. Slutsats: Anestesisjuksköterskor i USA har 
mer klinisk erfarenhet och teoretisk kunskap om opioidfri anestesi jämfört med svenska 
anestesisjuksköterskor. I Sverige behövs mer utbildning för att konceptet ska kunna 
implementeras säkert. Denna studie tyder på att opioidfri anestesi skulle vara fördelaktig för 
både svenska anestesisjuksköterskors omvårdnadsprioriteringar och för patienten i det 
postoperativa förloppet. 
 
Nyckelord: Opioidfri anestesi, OFA, Generell anestesi, Icke-opioida analgetika, 
Anestesisjuksköterka, Upplevelse, Erfarenhet 
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Abbreviations and definitions 
ASA – American Society of Anesthesiologists physical status classification system: 
 ASA I  healthy patient 
 ASA II mild systemic disease 
 ASA III  severe systemic disease 
 ASA IV  severe systemic disease with constant threat to life 
 ASA V  moribund patient not expected to survive without operation 
 ASA VI  organ donor (ASA House of Delegates/Executive Committee, 2014) 
BIS – Bispectral index 
Cardiac output – “The volume of blood passing through the heart per unit of time. It is 
 usually expressed as liters (volume) per minute” (Karolinska Institutet, 2016a) 
CNS – Central nervous system 
CRNA – Certified Registered Nurse Anesthetist in the United States 
EEG – Electroencephalography 
GABA – Gamma-aminobutyric acid 
Hemodynamic – “The movement and the forces involved in the movement of the blood 
 through the cardiovascular system” (Karolinska Institutet, 2016d) 
Induction – transition from being awake to under general anesthesia 
 (Karolinska Institutet, 2016c) 
MAC – Minimum alveolar concentration, (of anesthetic gases) 
Multimodal – “The treatment of a disease or condition by several different means  
 simultaneously or sequentially” (Karolinska Institutet, 2016b) 
NMDA – N-methyl-D-aspartate 
Nociception – “Sensing of noxious mechanical, thermal or chemical stimuli by nociceptors. It  
 is the sensory component of visceral and tissue pain” (Karolinska Institutet, 2016e) 
NSAID – Nonsteroidal anti-inflammatory drugs 
Nurse anesthetist – Used in this thesis to mean American CRNA and/or Swedish nurse 
 anesthetist 
Opioid-free anesthesia – Anesthesia without intraoperative opioids and an aim to reduce 
 perioperative opioids, commonly abbreviated OFA (Kremer & Griffis, 2018) 
Opioid-sparing anesthesia – Anesthesia with reduced opioid doses due to multimodal 
 analgesia (Kremer & Griffis, 2018) 
PONV – Postoperative nausea and vomiting 
PRST – Blood pressure, heart rate, sweating and tears 
RCT – Randomized controlled trial 
Rf AnIva – Riksföreningen för anestesi och intensivvård, National Association for 
 Anaesthesia and Intensive Care 
SRNA – Student Registered Nurse Anesthetist in the United States 
SSF – Svensk sjuksköterskeförening, The Swedish Society of Nursing 
TIVA – Total intravenous anesthesia 
Viscera – “Any of the large interior organs in any one of the three great cavities of the body, 
 especially in the abdomen” (Karolinska Institutet, 2016f) 
δ – delta 
κ – kappa  
μ – mu   
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Introduction 
Opioid addiction and overdose deaths are increasing problems in both Sweden and the United 
States (National Institute on Drug Abuse, 2019; Public Health Agency of Sweden, 2019). 
Opioids have a central role in suppressing pain stimuli, and are therefore commonly used in 
general anesthesia. However, opioids have several negative side effects such as: nausea, 
constipation, respiratory depression, stimulation of cancer cell proliferation and addiction 
(Kremer & Griffis, 2018). Several studies have suggested that a person who has never used 
opioids before surgery may have an increased risk to develop an addiction to opioids after 
surgery with traditional opioid-based anesthesia (Koepke et al., 2018). In recent years, 
methods to deliver general anesthesia without the use of opioids, so-called Opioid-Free 
Anesthesia (OFA), have been developed. Through randomized controlled trials (RCT), 
opioid-free anesthesia has been shown to minimize the negative side effects of opioids, while 
still delivering a safe and stable anesthesia. Nurse anesthetists are the main providers of 
anesthesia in both Sweden and the United States, and as such they have a responsibility for 
perioperative patient care and the drugs administered during anesthesia, as well as to stay 
continuously educated and updated on current evidence-based practice in their field 
(Riksföreningen för anestesi och intensivvård & Svensk sjuksköterskeförening [Rf AnIva & 
SSF], 2012). In the United States, opioid overdose deaths and opioid addiction is being 
discussed as the “opioid epidemic”, a public health emergency. According to nurse 
anesthetists Kremer and Griffis (2018), this calls for a paradigm shift in the treatment of pain, 
consequently focusing on the exclusion of opioids from anesthesia. The investigators and 
authors of this study participated in an Exchange Student Program with the University of 
North Florida, which sparked an interest to compare Swedish and American nurse 
anesthetists’ experiences with opioid-free anesthesia. 
 
Background 
General anesthesia 
Current medical practice requires anesthesia to perform humane surgical procedures on 
patients. To achieve optimal surgical conditions, the patient needs to be motionless, be 
unaware about what is happening and feel no pain. Historically, the first time this was 
achieved was in 1846 with the administration of diethyl ether (ether) during a surgical 
procedure. At the time, pain free surgeries were regarded as a miracle and this new 
phenomenon was named Anesthesia, from Greek meaning without sensation. Countless 
breakthroughs have since been achieved in the evolution of anesthesia in the one hundred 
seventy years since it was first implemented. The three primary groups of drugs used in 
modern general anesthesia are hypnotics, analgesics and neuromuscular blocking agents. To 
anesthetize a patient for general anesthesia, a combination of several different drugs needs to 
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be administered either through inhalation or intravenous access (Boon, Martini, & Dahan, 
2018; Robinson & Toledo, 2012). 
Hypnotics 
Hypnotic drugs are used to cause sleep and ensure that the patient is not aware during surgical 
procedures. Nitrous oxide gas was used in the early 1800s during dental procedures, but to 
provide tolerable pain levels the patient risked hypoxia (Robinson & Toledo, 2012). This led 
to the introduction of ether and the dawn of a revolution in pain free surgeries. Ether is a 
liquid drug, and could be administered through intermittent drips on a fabric placed over the 
mouth of the patient who inhaled it as a vapor. It has a stimulating effect on cardiac output 
and respiratory rate and causes bronchodilation. Ether, unlike other hypnotics, also has an 
analgesic effect both intra- and postoperatively (Chang, Goldstein, Agarwal, & Swan, 2015). 
However, ether is a volatile liquid with high flammability, a prolonged induction time, high 
incidence of nausea and vomiting and a persistent unpleasant odor. In 1932, the barbiturate 
sodium thiopental was developed for use as an induction agent. However, it was found to 
have a strong depressing effect on cardiac output. Propofol was introduced in 1977, and had 
the advantage of having a shorter recovery time than sodium thiopental, as well as having 
antiemetic properties (Robinson & Toledo, 2012). Halothane (the forerunner of today’s 
Isoflurane, Desflurane and Sevoflurane), discovered in the 1950s, completely replaced ether 
in the 1960s. The modern inhalation gases have the advantage of being less flammable and 
more potent, while causing less nausea and vomiting than ether, but also have a depressing 
effect on cardiac output and the respiratory drive. Consequently, in addition to analgesic 
drugs, heart monitoring and oxygen supplementation are needed when using modern 
hypnotics (Chang et al., 2015). 
Neuromuscular blocking agents 
To create optimal conditions for the surgeon to perform the procedure, the patient needs to be 
immobile. Temporary immobility can be achieved by a muscle relaxant. Muscle relaxation 
improves working conditions: for example during intubation, by relaxing the jaw for easy 
manipulation and better visualization of the vocal cords. Before the introduction of curare in 
1942, immobility was achieved by increasing the anesthetic doses, which not all patients 
tolerated hemodynamically. The increased use of muscle relaxation led to the need to secure 
the airway quickly, which spurred the invention of the laryngoscope and endotracheal 
intubation (Robinson & Toledo, 2012). Modern medicine currently uses two different groups 
of neuromuscular blocking agents, depolarizing and non-depolarizing, pharmacologically 
different, but with similar effects. Administering a neuromuscular blocking agent does not 
create hemodynamic changes in the patient, nor does it have an analgesic effect (Boon et al., 
2018). 
Analgesics 
Historically, distraction was used as an analgesic strategy during surgery. Analgesic drugs 
have a pain relieving effect, and include inhaled anesthetic agents, local anesthetics, opioids 
and some non-opioid drugs (Kremer & Griffis, 2018; Robinson & Toledo, 2012). For a 
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description of the non-opioid drugs included in the survey questions, please see Appendix 4: 
Non-opioid drugs. 
 
General anesthesia and pain 
The International Association for the Study of Pain (2017) define pain as “An unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or 
described in terms of such damage” (p1). Pain is a complex experience, greatly influenced by 
emotional, cultural and cognitive components (Bridgestock & Rae, 2013). The fact that pain 
is defined as an emotional experience implies that a person must be conscious and cognitive 
while experiencing pain. Thus, it can be considered inaccurate to refer to a patient as having 
“pain” during general anesthesia (Forget, 2019). However, with modern hypnotic drugs, 
nociception, which is the physiological detection of and reaction to harmful stimuli, persists 
despite hypnosis, unless blocked using intraoperative analgesic drugs. Upon surgical tissue 
damage, nociceptors in the skin and viscera send “pain”-signals to the central nervous system 
(CNS), via fast myelinated Aδ nerve fibers and slower unmyelinated C nerve fibers. This 
leads to stimulation of the sympathetic nervous system and is usually observed 
intraoperatively as increased blood pressure and heart rate, sweating and tears. (Cividjian et 
al., 2017). 
 
Opioids 
Opioids are a group of potent analgesic drugs known as narcotic analgesics. Opioids work 
mainly by binding to opioid receptors, primarily the mu (μ), kappa (κ) and delta (δ) receptors 
in the CNS, where they have an agonistic effect as they inhibit the afferent pain signals before 
they reach the brain (Kremer & Griffis, 2018). 
 
The use of opioids for treating pain dates back to the early 1800s, when Friedrich Sertürner, a 
German pharmacist, discovered how to isolate Morphine from opium (Trang et al., 2015). But 
it was during the 1960s, when the Belgian Paul Janssen developed the synthetic opioid 
fentanyl, that opioids became widely used in general anesthesia (Mulier & Dekock, 2017). 
During the latter part of the 20th century, fentanyl has been followed by numerous synthetic 
fentanyl analogues intended for use in anesthesia, for example sufentanil, alfentanil and 
remifentanil. These new synthetic drugs are designed with increased potency, more rapid 
onset and shorter duration to be more adapted to the anesthesia process (FASS, 2018b). 
Opioids in anesthesia 
Since patients under general anesthesia do not experience pain, opioids are administered for 
their sympathetic suppressive effect of the reaction to surgical stimuli, rather than their 
analgesic effect. Opioids counteract the elevation of blood pressure and heart rate associated 
with nociception (Lavand’homme & Estebe, 2018). 
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Before the 1960s, high doses of inhalation gases and barbiturates were the common methods 
of induction, causing a strong depressing effect on cardiac output. By combining inhalation 
gas and barbiturates with opioids, a synergistic effect was created, which led to a dose 
reduction in the hypnotic drugs required for induction.  
 
Opioids were responsible for both suppressing the sympathetic system and offering 
hemodynamic stability, especially for patients who suffered from undiagnosed cardiovascular 
diseases, which was more prevalent before the 1960s (Koepke et al., 2018). Opioids even 
have a crucial role in the protective mechanism of myocardial ischemic preconditioning. By 
activating δ and κ receptors, opioids reduce myocardial tissue damage during ischemia 
(Kremer & Griffis, 2018; Tanaka, Kersten, & Riess, 2014). 
 
Currently, one of the most common anesthesia regimes of care in Sweden is total intravenous 
anesthesia (TIVA), with propofol and remifentanil administered via target controlled infusion 
(TCI)-pumps, and titrating the anesthesia according to the cerebral and plasma concentration 
level (Spetz, 2018). The fentanyl analogue remifentanil, ideal for use during general 
anesthesia with its almost immediate onset and ultra-short duration, can be titrated to adequate 
effect with ease. Remifentanil does not accumulate during continuous infusions, hence 
offering rapid recovery (Kremer & Griffis, 2018; Santonocito, Noto, Crimi, & Sanfilippo, 
2018). 
Negative effects of opioids 
Opioids have numerous negative side effects. Respiratory depression following a high dose of 
opioids is caused by a disruption in the respiratory center in the brainstem. It can last for 
several hours, suppressing the respiratory drive normally activated by increased levels of 
carbon dioxide (Kremer & Griffis, 2018).  
 
The occurrence of postoperative nausea and vomiting (PONV) is more common when the 
patient has been administered opioids (Kremer & Griffis, 2018). PONV is associated with 
patient suffering and increased cost of care due to extended hospital stays (Hooper, 2015). 
Assessing the patient's individual risk factors of developing PONV, the Apfel Score uses a 0-
4 point scale. It was validated for patients undergoing anesthesia with benzodiazepine for 
premedication, induction with thiopental and fentanyl, and the use of volatile anesthetic gas as 
maintenance (Apfel, Läärä, Koivuranta, Greim, & Roewer, 1999). 
  
Urinary retention is caused by opioids tightening the sphincter muscle, and constipation can 
occur when opioids affect the intestines and decrease gastric motility. Both have the potential 
for causing serious complications and extended hospital stays. Orthostatic hypotension and 
syncope are caused by venous pooling when rising from a horizontal position. This is more 
common when the patient has been administered opioids, and can interfere with early 
ambulation (Hontoir et al., 2016; Kremer & Griffis, 2018). 
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Opioid-induced hyperalgesia is a paradoxical increased sensitivity to painful stimuli following 
opioid administration, leading to higher postoperative analgesic requirement. This is likely 
caused by central sensitization to pain (Santonocito et al., 2018). This opioid paradox is 
described as “the more opioids used intraoperatively, the more opioids required 
postoperatively” (Koepke et al., 2018, p. 2).  
  
Opioid tolerance is when the same dose of opioids gradually generates less analgesia, thus 
requiring higher doses over time. It is caused by repeated opioid administration, which 
reduces the activation of opioid receptors achieved by a given dose (Santonocito et al., 2018). 
  
Opioid dependence is caused by opioid stimulation to release the neurotransmitter dopamine, 
which is linked to feelings of well-being and reward, as well as increased risk-taking to seek 
pleasure. Gradually, because of tolerance, less dopamine is released with every opioid dose, 
leading to pursuit of higher doses, and the emergence of negative emotions upon withdrawal 
from opioids. Opioid withdrawal, stopping, or decreasing opioid use also gives rise to several 
negative symptoms such as tachycardia, hypertension, diarrhea, insomnia and increased pain 
(American Psychiatric Association, 2013). This may eventually lead to addiction, which is the 
most severe form of substance-use disorder with substantial loss of self-control (Volkow, 
Koob, & McLellan, 2016). 
Opioid prescription and abuse 
In 2017, the opioid epidemic in the United States was declared a public health emergency by 
the government. Opioid abuse and addiction is not a new occurrence, but the recent outbreak 
can be traced back to the late 1990s, when a different perspective on pain as well as its 
treatment was adopted. Guidelines developed in the United States promoted the assessment 
and treatment of acute and chronic pain. Pain control policy during that time encouraged 
treatment with opioids. Opioids were promoted as safe and with a low risk of causing 
addiction. The fact that the pharmaceutical industry both funded the policy and had policy 
developers on payroll led to an increase in opioid prescriptions (Koepke et al., 2018). Since 
the year 2000 there has been a quadruple increase in deaths due to overdoses involving 
prescriptions and illegal opioids (Mauermann, Ruppen, & Bandschapp, 2017).  
 
Postoperative prescription of opioids is associated with a higher risk to develop long term use, 
abuse, addiction and overdose. The longer the first period of opioid use, the higher the risk to 
develop a long-term addiction. Studies exploring the quantity of pills prescribed after 
different surgeries found that it could range from 0 to 120 pills. A prescription of an opioid 
after surgery is often the beginning of a chronic opioid use, and pills not taken postoperatively 
could be used for nonmedical purposes by someone other than the patient (Brandal et al., 
2017; Koepke et al., 2018; Kremer & Griffis, 2018). 
 
Opioid dependence has become wide spread in the United States, where opioid overdose 
currently is the leading cause of accidental deaths, exceeding deaths due to motor vehicle 
Pihlblad & Verbeeck 
6 
 
accidents. The opioid epidemic and the negative effects of opioids following anesthesia has 
spurred the clinical trials to reduce the use of opioids in anesthesia practice (Koepke et al., 
2018). 
Opioid overdose deaths 
In Sweden, 626 narcotics related deaths occurred in 2017, of which more than 95% were 
related to opioids. Non-voluntary intoxication (overdose) was reported as the most common 
cause of narcotic related death, as well as the cause that has increased the most in recent years 
(Public Health Agency of Sweden, 2019). With a population of 9.995 million in 2017, this 
equals to 6.0 of 100,000 inhabitants. The corresponding number in the United States was 
47,600 opioid related overdose deaths. With a population of 325.7 million in 2017, this equals 
to 14.6 of 100,000 inhabitants (National Institute on Drug Abuse, 2019). According to these 
numbers, opioid overdose death is more than 2.4 times as common in the United States than 
in Sweden. 
 
Multimodal analgesia 
Suppressing the hemodynamic reaction to surgical tissue damage can be achieved with 
different groups of opioid and non-opioid analgesic drugs. Using two or more different drugs, 
creating a synergistic or additive effect to reduce the doses of individual drugs, is called 
multimodal analgesia. Achieving the additive effects can minimize negative side effects while 
still managing to achieve adequate analgesia. Combining a reduced dose of a hypnotic agent 
with one or several analgesic agents during induction of anesthesia can suppress the 
hemodynamic reaction of intubation (Mauermann et al., 2017; Robinson & Toledo, 2012). 
Regional anesthesia with neuraxial and peripheral nerve blocks can be combined with general 
anesthesia to reduce opioid use (Koepke et al., 2018). N-methyl-D-aspartate (NMDA) 
receptor antagonists, alpha 2-agonists, magnesium sulfate, intravenous lidocaine and 
corticosteroids all have analgesic or antinociceptive effects and can be used as adjuvants or 
substitutes for opioids during anesthesia (Kremer & Griffis, 2018; Mauermann et al., 2017) 
The same principle can be applied to postoperative analgesia. The most common non-
prescription, non-opioid analgesic drugs used to treat postoperative pain are paracetamol and 
COX-inhibitors, or nonsteroidal anti-inflammatory drugs (NSAID). Administered together, 
paracetamol and NSAIDs reduce the need of opioids postoperatively, thus having an opioid-
sparing effect. Multimodal analgesia is the foundation of opioid-free or opioid-sparing 
techniques (Kremer & Griffis, 2018; Mauermann et al., 2017). 
 
Opioid-free anesthesia 
Opioid-free anesthesia, as the name implies, is anesthesia without the use of opioids. 
Generally, opioids are avoided both pre- and postoperatively when the concept is clinically 
practiced, thus only relying on opioids as a last resort rescue analgesic (Koepke et al., 2018). 
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Clinical trials with opioid-free anesthesia 
Many researchers have conducted clinical trials to validate the implementation of an opioid-
reduced or opioid-free approach to the perioperative process.  
 
An RCT by Bakan et al. (2015) investigated opioid-free anesthesia comparing the drugs 
propofol, dexmedetomidine and lidocaine versus remifentanil during laparoscopic 
cholecystectomies. A significant reduction of the need of rescue analgesics was observed 
early postoperatively, later equal results were found. The difference in occurrence of PONV 
was not statistically significant, but the use of rescue antiemetic drugs decreased. The 
conclusion was that opioid-free anesthesia can be an alternative, especially for patients at high 
risk for PONV.  
 
An RCT by Hontoir et al. (2016) hypothesized that opioid-free anesthesia with ketamine, 
lidocaine and clonidine would give higher rates of self-defined patient comfort in recovery 
after breast cancer surgery, compared to remifentanil-based anesthesia. The result showed a 
statistically significant increase of comfort with the opioid-free group, however the increase 
was slightly smaller than what the researchers deemed clinically relevant. Opioid-free 
anesthesia was still determined as a safe method for the patient group.  
 
Brandal et al. (2017) implemented an opioid-free routine for colorectal surgery using 
ketamine, lidocaine and neural blocks, and evaluated the impact it had on opioid 
consumption. Although the intraoperative use of opioids was significantly reduced, no 
significant difference in discharge dose and quantity of prescription opioids was seen. Patients 
with low pain scores at discharge, low consumption of opioids postoperatively, and no opioid 
use preoperatively still received opioid prescriptions. This suggests that the behavior of the 
physician, rather than the patient’s medical condition, may be the primary determinant for 
prescriptions of opioids. 
 
The evidence shows that opioid-free anesthesia yields equal or improved postoperative patient 
outcome regarding negative effects such as PONV and postoperative pain. Opioid-free 
anesthesia is emerging as a valid alternative to traditional opioid-based anesthesia and may 
assist in solving the opioid epidemic (Koepke et al., 2018). 
 
Although these clinical trials validated one combination of non-opioid drugs for a specific 
surgical procedure, more studies are needed to cover all fields of surgery, and the best 
available evidence needs to be determined using meta-analysis. Current evidence has not yet 
determined the ideal combination of non-opioid analgesics, nor validated the regime for a 
large number of surgical procedures (Mulier & Dekock, 2017). 
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Depth of anesthesia 
Guedel’s classification of anesthesia was developed by the American anesthesiologist Arthur 
Guedel in 1937 and was originally based on ether anesthesia. The classification defines four 
stages of the depth of anesthesia, with the third stage being divided into four planes of 
surgical anesthesia. The clinical signs used by Guedel are respiration, eye activity, pupil 
dilation and reflex, eyelid reflex, and muscular responses such as swallowing. These are still 
used today, although newer anesthetic agents, opioids and muscle relaxants alter the clinical 
responses, rendering Guedel’s classification slightly obsolete (Jameson & Sloan, 2006). 
Opioids, for example, are known to constrict the pupil in a way that was not observed by 
Guedel. Furthermore, the classical stages in Guedel’s classification can be concealed when 
using multiple drugs to achieve multimodal analgesia or balanced anesthesia (Rani & 
Harsoor, 2012). 
 
A similar assessment tool is known as the PRST-score and was developed in the 1980s. This 
uses the clinical signs blood pressure, heart rate, sweating and tears (PRST) to evaluate the 
adequacy of anesthesia. It has later been proposed that the PRST-score is a better indication of 
the adequacy of analgesia, that is suppression of responses to painful stimuli, rather than the 
hypnosis or depth of anesthesia (Warrén Stomberg, Sjöstrom, & Haljamae, 2001). 
 
To avoid both too deep anesthesia, with a risk of impaired postoperative cognitive function, 
and too shallow anesthesia, with a risk of awareness, different techniques to measure the 
depth of anesthesia have been developed (Sinha & Koshy, 2007). Since the effect of various 
drugs and doses is individual, merely measuring drug concentration in μg/ml (TCI) or 
minimum alveolar concentration (MAC) is not always perceived to be sufficient. The brain is 
the target organ for all general anesthetics, and therefore different variants of 
electroencephalography (EEG) can be used. Bispectral index (BIS) is one such method, where 
the EEG is processed and converted to display a number between 0 and 100. A value between 
40 and 60 is consistent with adequate anesthesia. A lower index value is correlated with 
longer periods of burst-suppression and isoelectric EEG, meaning heavily suppressed cortical 
activity. However, any modified EEG-method is less accurate in monitoring the depth of 
anesthesia when drugs that do not target the gamma-aminobutyric acid receptor (GABAA) are 
used, such as ketamine and nitrous oxide (Rani & Harsoor, 2012). This means that BIS and 
other EEG-based depth of anesthesia monitors may be less reliable when used together with 
opioid-free anesthesia. 
 
Role of the nurse anesthetist 
The Swedish healthcare system aims to provide care on equal terms for the entire population. 
Healthcare shall be practiced with respect for the equal value of all people and the dignity of 
all individuals. Priority is given to those with the greatest needs, and the healthcare system 
strives to prevent illness (SFS 2017:30). 
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In both Sweden and the United States, anesthesia is administered by nurse anesthetists. A 
nurse anesthetist can independently induce, maintain, and awaken a patient from general 
anesthesia, with only varying degrees of support from a physician anesthesiologist. The nurse 
anesthetists’ main priority is anesthesiological care of the patient throughout the perioperative 
setting, based on the resources and needs of every individual. This requires knowledge of both 
medicine and nursing science (Rf AnIva & SSF, 2012).  
 
The Swedish Society of Nursing collaborates with the American initiative Quality and Safety 
Education for Nurses to promote the six core competences of the specialist nurse, one of 
which is evidence-based practice (Disch, 2012). Evidence-based practice is to apply the best 
available scientific evidence from research to implement good, effective care of the individual 
patient. In the nursing process, all steps need to be scientifically substantiated by evidence-
based practice. In scientific medical research, RCTs and meta-analysis of RCTs are regarded 
as the gold standard for evidence (Johansson & Wallin, 2013; Walker & Avant, 2019). 
 
In the United States, nurse anesthetists are Advanced Practice Nurses, meaning they practice 
with a high degree of autonomy. In some states, they are able to assess, plan and administer 
anesthesia without supervision of a physician.  
 
In Sweden, the nurse anesthetist is required indirect supervision by a physician, who assesses 
the patient and prescribes the anesthesia. Patients classified as American Society of 
Anesthesiologists (ASA) physical status I and II can be anesthetized by the nurse anesthetist 
independently for elective procedures, while collaboration with a physician anesthesiologist is 
required for ASA III to V-patients and emergency procedures (Rf AnIva & SSF, 2012).  
 
The length of the postgraduate education required to become a nurse anesthetist is also 
different, being one year in Sweden and three years in the United States. Additional 
recertification is required every two to four years in the United States (National Board of 
Certification and Recertification for Nurse Anesthetists, 2019). American nurse anesthetists 
are trained to establish regional anesthesia through for example spinal and epidural blocks, 
which are performed by physician anesthesiologists in Sweden. 
 
Both nurse anesthetists and physician anesthesiologists have a responsibility for the drugs 
they administer during anesthesia (HSLF-FS 2017:37). In Sweden, the nurse anesthetists 
work on prescriptions from the physician, while in the United States, the nurse anesthetists 
have a greater responsibility to individually plan and choose their anesthesia. The role of the 
nurse anesthetist regarding choice and administration of opioids may therefore be different in 
Sweden and the United States. However, it is their understanding and approach to opioid-free 
alternatives that could be vital for patients in both nations. 
 
Pihlblad & Verbeeck 
10 
 
The majority of articles on opioid-free anesthesia found in scientific databases are medical 
studies with quantitative approaches. The nursing perspective of opioid-free anesthesia needs 
to be further researched, both quantitatively and qualitatively. As the nurse anesthetists are the 
ones closest to the patient during anesthesia, their experience and perspective of a possible 
paradigm shift in analgesia may prove important to investigate (Kremer & Griffis, 2018). 
 
Problem statement 
Opioids have played a central role in anesthesia for decades, despite their numerous negative 
side effects, which include respiratory depression, hyperalgesia, tolerance and addiction. 
Opioid addiction and opioid overdose deaths are increasing in both Sweden and the United 
States. Several RCTs show that opioid-free anesthesia can be an alternative to traditional 
opioid-based anesthesia, and nurse anesthetists need to be updated on the current evidence-
based practice. However, there seem to be relatively few studies that illustrate the nurse 
anesthetists’ perspective on administering opioid-free anesthesia. The role of the nurse 
anesthetist puts them in a position to influence both patient safety during anesthesia and 
postoperative patient outcome. Their role regarding choice and administration of opioids may 
be different in Sweden and the United States, but their understanding of and approach to 
opioid-free alternatives could be conclusive for patients in both nations. As the investigators 
participated in an Exchange Student Program with the University of North Florida, we had an 
interest in comparing Swedish and American nurse anesthetists’ experiences with opioid-free 
anesthesia. 
 
Aim 
The aim of this study is to compare experiences among nurse anesthetists in Sweden and the 
United States with regards to their familiarity with opioid-free anesthesia, its perioperative 
risks and benefits, and the perceived connection between intraoperative opioids and 
postoperative addiction. 
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Methods 
Design  
In this study, a non-experimental quantitative method was utilized to perform a cross-
sectional comparison between the experience of opioid-free anesthesia in the two pre-existing 
groups: Swedish and American nurse anesthetists. To reach as many nurse anesthetists in 
Sweden and the United States as possible, and increase the generalizability of the study, data 
collection was made with a web-based survey (Polit & Beck, 2012). 
 
Development of survey 
A web-based survey was developed in two language versions, one in English and one in 
Swedish (see appendices 1 and 2). Both versions consisted of the same 20 questions, and 
dichotomous questions were used to collect demographic data. The majority of the survey 
questions were multiple-choice questions on a Likert scale with five response alternatives: 
from strongly agree to strongly disagree. For specific statements regarding opioid-free 
anesthesia, a sixth response option was included: I don’t know. Likert scales can be used to 
quantitatively compare attitudes between different people, as both the intensity and direction 
of opinions can be measured (Polit & Beck, 2012). 
 
The surveys were designed using Google Forms with the intent to perform parallel 
comparisons. Dr. John McDonough, Director of the Nurse Anesthesia Program at the 
University of North Florida, collaborated with the principal investigators in the formulation of 
the survey questions, using his anecdotal clinical knowledge and with evidence from 
literature.  Along with students from the University of North Florida and the University of 
Gothenburg, the questions were validated in the English language and Swedish translation 
respectively. 
 
Sample 
In Sweden, eight different anesthesia clinics were included in the survey: seven in 
southwestern Sweden and one in central Sweden. The inclusion criterion was to be an actively 
practicing nurse anesthetist in at least one of the chosen clinics. Contact was made by email to 
the operations managers of the clinics, and the nurse anesthetists were invited to participate 
after permission was granted by their respective managers. Consecutive sampling was used 
since all nurse anesthetists in the accessible population were invited to participate during the 
time period the survey was active. It was also a convenience sampling since the investigators 
chose to include easily accessible clinics (Polit & Beck, 2012).  
 
In the United States, consecutive sampling was used as the survey was posted on-line in two 
closed groups for nurse anesthetists on the social media network Facebook. Inclusion criteria 
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were: to be a nurse anesthetist or student nurse anesthetist, have a Facebook membership and 
be a member of at least one of the closed groups. Both convenience and consecutive 
samplings are considered nonprobability (non-random) sampling methods (Polit & Beck, 
2012). 
 
Data collection 
Initially, survey responses in the United States were collected in-person using a tablet with 
internet access at a hospital in North Florida. This was found to be ineffective considering the 
available time, and a link to the survey was instead posted on Facebook. The link was active 
for 26 days, although all responses came in the first week after publication. 
 
In Sweden, the survey was distributed by email to nurse anesthetists by the operations 
managers of the participating clinics. The investigators did not have access to the emailing 
lists. In total, 318 Swedish nurse anesthetists received the invitation to participate in the 
survey, which was active for 14 days. 
 
Data analysis 
When the online surveys had been closed, the data was exported from Google Forms to 
Microsoft Office Excel (version 16.24). Answers on the Likert scales were converted to 
numbers, with 5 equaling strongly agree, 4 equaling agree and so on, with 0 being used to 
represent I don’t know. The data was subsequently imported to SPSS Statistics (version 25.0, 
IBM Corp., Armonk, New York, USA), which was used to calculate descriptive statistics 
such as means, medians, standard deviations and valid percentages of answers. The answers 
on the Swedish and American versions of the surveys were handled separately. Data was then 
transferred back to Excel, which was used to create charts that compare the Swedish and 
American answers by showing the distribution of answers within each nation. In this step, 
Swedish and American data was displayed next to each other in the same charts. Throughout 
the process, both investigators were present to make sure no errors were made in the handling 
of the numbers. 
 
Ethical considerations 
The ethical principles for research involving human subjects stipulated by the Declaration of 
Helsinki were followed in the process of conducting this study (World Medical Association, 
2013). There were no direct advantages or disadvantages for participants to partake in this 
non-experimental study. The information to the study participants (appendix 3) highlighted 
that participation was voluntary and explicitly stated any risks of joining the study.  
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Non-experimental studies can imply a certain risk of discomfort (Polit & Beck, 2012). A web-
based survey is probably less prone to generate feelings of discomfort or bad memories than 
an interview situation, but opioids can be a sensitive topic for some people. It was therefore 
stressed that the option to leave certain questions unanswered existed. Advantages of 
participation could be that the study stimulated reflection upon opioid-free anesthesia, both 
within the individual nurse anesthetist and in the workplace. Participants could also contribute 
with valuable information for exchange of knowledge and experience between the two 
participating nations.  
  
Consent to participate in the study was given when the survey was sent in electronically. Until 
that point, participation could be aborted and any answers would be erased. Questions about 
personal data such as age and gender were possible to leave unanswered if the participant so 
chose. Response data from the surveys was password protected and handled with 
confidentiality by none other than the principal investigators. 
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Results 
The total number of respondents was 61 Swedish nurse anesthetists, and 107 American nurse 
anesthetists and student nurse anesthetists. One (1) respondent was regarded as internal 
omission and excluded from the Swedish survey since only one question had been answered 
(figure 1). 
 
 
Figure 1. Flow chart of samples and responses in Sweden and the United States. (RR=response rate, 
CRNA=Certified Registered Nurse Anesthetist, SRNA=Student Registered Nurse Anesthetist) 
Percentages are presented as valid percent (%) in all figures, meaning the percentage of valid 
answers to each question. 
 
Demographics 
No noteworthy difference was seen between the respondents reported age in Sweden and the 
United States. There was a gender distribution difference, with almost half of the American 
respondents identifying as male, while less than one fourth of the Swedish respondents 
identified as male. Years of experience was reported similarly, with the majority of the 
respondents in both nations having more than five years of experience. In the United States, 
some of the respondents were Student Registered Nurse Anesthetists. In Sweden, only nurse 
anesthetists responded to the survey. Respondents from Sweden most commonly practiced at 
a university hospital, while the American respondents were not asked to specify what type of 
hospital they practiced at. 
 
318 
nurse anesthetists in Sweden
61 
responses to Swedish survey
1 
internal omission
60
responses analyzed in study
107 
responses to U.S. survey
107
responses analyzed in study
RR=19% RR=unknownRR=100%
6
CRNAs at a U.S. hospital
Unknown number of
CRNAs & SRNAs on Facebook
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Table 1. Demographic data presented as numbers, means, medians, standard deviation (Std. Dev) and valid 
percent (%). (SRNA=Student Registered Nurse Anesthetist) 
 
Familiarity with opioid-free anesthesia 
In the United States, 92% of the respondents reported familiarity with the concept of opioid-
free anesthesia (agree + strongly agree; figure 2). The corresponding number in Sweden was 
48%. Disagreement with the statement was 4% in the United States (disagree + strongly 
disagree). The corresponding number in Sweden was 44%. 
 
 
Figure 2. Familiarity with the concept of opioid-free anesthesia. (Sweden n=59, United States n=107) 
This next question inquired both theoretical and practical knowledge about opioid-free 
anesthesia (figure 3). Approximately half of the respondents in the United States reported 
practicing opioid-free anesthesia clinically at least once a week. Clinical practice (at least: 
once a week + once a month + once a year) was reported by 69% of the American 
respondents, while this was reported by 24% of the Swedish respondents. More than 7 in 10 
respondents in the United States reported having obtained knowledge about opioid-free 
United States Sweden United States Sweden
Category
Total number Nurse anesthetist n96 89,7%  n60 100%
of responses n107 n60 SRNA n11 10,3%  n0 0%
Year of birth Years of experience in anesthesia
Responses n104 n59 0-2 years  n9  8,4%  n13 21,7%
Mean 1974,35 1973,54 3-5 years  n19  17,8%  n9 15%
Median 1975 1975 6-10 years n21  19,6%  n11 18,3%
Std. Dev 10,53 11 11-15 years n19  17,8%  n6 10%
Minimum 1947 1954 ≥ 16 years  n28  26,2%  n21 35%
Maximum 1993 1989 
Type of hospital
University hospital n25 41,7%
Gender Region hospital n19 31,7%
Female n57 53,3% n46 76,7% Hospital n16 26,7%
Male n50 46,7% n14 23,3% Unspecified n107 100% n0 0%
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anesthesia from scientific articles. In Sweden, 55% reported having no knowledge about 
opioid-free anesthesia. 
 
 
Figure 3. Origin of knowledge and frequency of clinical practice. (Sweden n=60, United States n=107) 
Of the American nurse anesthetists, 85% reported agreement with the statement that the 
evidence supports the use of opioid-free anesthesia (agree + strongly agree; figure 4). In 
Sweden, the majority of the respondents chose the alternative I don’t know. No one strongly 
disagreed to the statement in either nation, and only 2% of the American respondents 
disagreed. 
 
 
Figure 4. Opinion that the evidence supports the use opioid-free anesthesia. (Sweden n=60, United States 
n=106) 
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Benefits 
The majority of respondents in the United States chose to agree and strongly agree with the 
statement that opioid-free anesthesia has benefits in all the categories in the question 
(appendix 5, figure 11). The categories with the most agreement were avoiding constipation 
(agree + strongly agree = 95%) and risk of PONV (agree + strongly agree = 92%). The least 
agreement was reported with the categories postoperative pain (agree + strongly agree = 
72%) and patients’ desires (agree + strongly agree = 72%). 
 
The majority of the Swedish respondents chose the alternative I don’t know on all the benefits 
except risk of PONV (appendix 5, figure 12). Risk of PONV was the only category where 
majority of the respondents agreed (agree + strongly agree) to opioid-free anesthesia having 
benefits. 
 
Risks 
The majority of the American respondents disagreed to the statement that opioid-free 
anesthesia has any of the listed intraoperative risks (figure 5). However, 20% of the 
respondents indicated that there was a risk of heart rate: too high, and 14% agreed that blood 
pressure: too high was a risk, although no one chose the alternative strongly agree to any risk. 
Fewer respondents thought that heart rate: too low and blood pressure: too low was a risk, 
with the percentages 2% and 3% respectively. In the Swedish survey, more than 60% of the 
respondents chose the alternative I don’t know to all the categories. 
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Figure 5. Comparison of perceived intraoperative risks of opioid-free anesthesia between Sweden and the 
United States. (n= see figure) 
 
Drugs in the opioid-free anesthesia regime of care 
Of the drugs listed, only nitrous oxide received less than 50% of the American respondents’ 
agreements to be included in an opioid-free anesthesia regime of care (appendix 5, figure 13). 
The most popular drugs to be included were ketamine, lidocaine, propofol, ketorolac and 
paracetamol, with more than 90% agreements respectively (agree + strongly agree). 
 
The most popular drugs to include according to the Swedish respondents were paracetamol, 
propofol, lidocaine and clonidine. I don’t know-answers ranged from 36% to 75%, with the 
least amount of I don’t know-answers on paracetamol and the most on magnesium (appendix 
5, figure 14). 
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Respondents were also asked to report their familiarity with the non-opioid drugs listed in the 
survey. The majority of the American respondents chose to strongly agree with being familiar 
with all the non-opioid drugs listed in the survey except clonidine (appendix 5, figure 15). 
 
The Swedish respondents reported the least familiarity with magnesium and 
dexmedetomidine, with less than 50% agreements respectively (appendix 5, figure 16). 
 
Measuring the depth of anesthesia  
Differences were reported in the perceived importance of depth of anesthesia monitoring 
between Sweden and the United States (figure 6). In Sweden, 72% of respondents thought it 
was important to measure depth of anesthesia, while only 31% thought it was important in the 
United States. 
 
 
Figure 6. Measuring depth of anesthesia in all general anesthetics. (Sweden n=60, United States n=107) 
Respondents who answered yes were asked to specify under which circumstances depth of 
anesthesia was monitored (appendix 5, figure 17). In the United States, the two most 
frequently selected alternatives were only for patients “at risk” and rarely or never, and in 
Sweden, the most frequently selected alternatives were when a monitor is available and 
always. 
 
The perceived importance of measuring depth of anesthesia in opioid-free anesthetics differed 
from the perceived importance of measuring in all general anesthetics (figure 7). In the United 
States, a higher percentage of respondents thought it was important to measure depth of 
anesthesia in opioid-free anesthesia than in all general anesthetics. The alternative I don’t 
know was selected by 38% in Sweden, and 11% in the United States. Of all questions in this 
survey, this question generated the highest percentage of I don’t know-answers from 
respondents in the United States. 
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Figure 7. Measuring depth of anesthesia in opioid-free anesthesia general anesthetics. (Sweden n=60, United 
States n=107) 
 
Opioid-free anesthesia and opioid addiction 
In the United States, 93% of the respondents considered opioid addiction to be a major 
problem in society (agree + strongly agree), while in Sweden, 69% agreed and strongly 
agreed (figure 8). In Sweden, 32% were neutral, disagreed or strongly disagreed to the 
statement, while in the United States, the corresponding percentage was 8% of the 
respondents. 
 
 
Figure 8. Opinions of opioid addiction being a major problem in society. (Sweden n=60, United States n=107) 
In both nations, the majority of the respondents had the opinion that patients who have a 
history of opioid abuse should receive opioid-free anesthesia (figure 9). In the United States, 
85% agreed to the statement (agree + strongly agree), while the corresponding number in 
Sweden was 51%. One third of the Swedish respondents chose the alternative I don’t know. 
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Figure 9. Opioid-free anesthesia for patients with opioid abuse or dependence. (Sweden n=60, United States 
n=106) 
The majority of the American respondents agreed to the statement that administering opioids 
intraoperatively can lead to opioid dependence (agree + strongly agree; figure 10). The 
corresponding number in Sweden was 22%. Disagreement to the statement was reported by 
27% of American and 45% of Swedish respondents (disagree + strongly disagree). 
 
 
Figure 10. Intraoperative opioids leading to opioid dependence. (Sweden n=60, United States n=107) 
 
Side effects to avoid 
As a last question, the respondents were asked which side effects of anesthesia were perceived 
as important to avoid in all anesthesia practice. This was a question designed to identify the 
nurse anesthetists’ priorities in the perioperative patient care. The majority of the American 
respondents agreed to all the statements (appendix 5, figure 18). The only category with total 
agreement was PONV (agree + strongly agree = 100%). 
 
The majority of the Swedish respondents also agreed to all the statements (appendix 5, figure 
19). The categories with the most agreements were PONV and postoperative pain (agree + 
strongly agree = 100%).   
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Discussion 
Method discussion 
Design 
The aim of this study was to compare experiences of opioid-free anesthesia between nurse 
anesthetists in Sweden and the United States. Since the aim was to compare these pre-existing 
groups, a non-experimental quantitative method was appropriate (Polit & Beck, 2012). This 
may have led to some disadvantages compared to a qualitative method, the most prominent 
being that a qualitative study could have given a deeper understanding of the nature and 
expression of these experiences. To be able to compare experiences between Swedish and 
American nurse anesthetists, first the experiences needed to be made quantifiable. By 
describing complex phenomena such as experiences by using numbers, the investigators have 
used a positivist approach. Positivism implies that an objective reality exists, which is 
studiable and measurable, and that this reality exists independently of human observation 
(Polit & Beck, 2012). To measure this reality, we have collected empirical data, compared it 
and drawn conclusions from it.  
Sample 
The target population was all actively practicing nurse anesthetists in Sweden and the United 
States. The accessible population depended on the method of distribution of the survey, and 
efficiency in the distribution was valued highly due to time constraints. No advantage was 
seen from using probability (random) sampling instead, since the aim was to include as many 
nurse anesthetists as possible. Probability sampling would rather lead to random exclusion of 
some nurse anesthetists, as to decrease the sample size (Polit & Beck, 2012), which we did 
not consider necessary.  
 
In Sweden, the sample consisted of nurse anesthetists in southwestern and central Sweden. 
Distribution to the entire nation’s nurse anesthetists was desired but not possible, leading to a 
possible convenience sampling bias (Polit & Beck, 2012). In the United States, the survey 
was distributed via Facebook. This led to an unintended inclusion criterion of being a 
registered user of the social media platform.  
 
The response rate in Sweden was 19 %. In the United States, the response rate is unknown, 
because membership sizes of the closed groups used to distribute the survey is unclear. 
Possible numbers range up to approximately 25.500. The investigators consider this number 
to be unsuitable for response rate calculation, since group membership does not necessarily 
equal becoming aware of the survey. Social media content distribution is based on complex 
algorithms, which do not guarantee visibility of the survey to all members unless actively 
searched for, neither do they distribute content randomly (Peruta & Shields, 2018). The fact 
that American responses were only collected within the first week of publication indicates 
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that the survey may not have reached the intended population or sample, rendering response 
rate calculation very difficult.  
 
As we used a web-based survey, a low response rate could be expected. This may have led to 
nonresponse bias, since nonresponse is also not considered to be random (Polit & Beck, 
2012). This can be considered a weakness in our study, as an interest in the study topic is 
known to increase the individual’s willingness to participate. More nurse anesthetists with 
particularly strong opinions, both positive and negative on opioid-free anesthesia, may have 
chosen to participate than the average nurse anesthetists in the two respective nations. This 
may be particularly prominent in the American version of the survey, since it was distributed 
using social media and not through the practitioners’ workplaces, as employee surveys tend to 
have higher response rates (Saleh & Bista, 2017). This may decrease the generalizability of 
our study. However, the investigators consider the distribution between answers to be wide 
enough to indicate that nonresponse bias still is low, and therefore believe some 
generalization can be made.  
  
In Sweden, to increase the validity and generalizability of the study, the investigators sought 
to include many different specialties of anesthesia clinics. However, some of the operations 
managers in Sweden expressed reluctance to let their nurse anesthetists participate, owing to a 
belief that they would not be able to answer the questions, since the clinic did not practice 
opioid-free anesthesia. After clarifying to the operations managers that the survey was 
designed for all nurse anesthetists to be able to answer all the questions, these clinics also 
agreed to be included in the study. Yet some nurse anesthetists may have had the same 
opinion, thus choosing not to participate, leading to another source of possible nonresponse 
bias (Polit & Beck, 2012). 
Data collection 
Data collection was made with a web-based survey. This has several advantages compared to 
interviews or surveys on paper. It is for example time- and cost effective since it can reach a 
large amount of people in a short amount of time. It is also a means to guarantee anonymity 
and may therefore give more truthful answers. Provided that the survey is well developed, any 
bias from the investigators can be eliminated. Disadvantages could be that questions can be 
misunderstood, closed questions with given answers can give less information than open 
questions, and the response rate tends to be low (Polit & Beck, 2012).  
 
The investigators first used a tablet with the survey, collecting answers in-person at a hospital 
in the United States. This method yielded a high response rate, although it was inefficient 
related to the available time, whereby subsequent publication on Facebook was chosen. While 
the investigators are aware that this lack of rigor in the sampling plan may decrease the 
reliability of the study, the six responses collected in-person were ultimately not perceived to 
affect the final results enough to warrant their exclusion (Polit & Beck, 2012). 
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Validity and reliability 
Great importance is placed on the survey’s validity, ensuring that the survey questions 
measure according to our aim. The survey becomes an instrument for data collection and its 
construction and structure are imperative for the quality of the collected data. (Polit & Beck, 
2012). Since no pre-existing survey existed that could be used to answer our aim, a new 
survey had to be developed. The surveys in the present study were developed with the 
assistance of Dr. John McDonough, Director of the Nurse Anesthesia Program at the 
University of North Florida, and our supervisor at the University of Gothenburg, who both 
also validated the questions. There is congruence between the wording of questions between 
the two survey versions, as students from both universities helped to validate the survey and 
its translation, and their feedback was used to improve the final version (Trost & Hultåker, 
2016). However, during the data analysis, it became apparent that the wording of some 
questions could be slightly unspecific, leading to possible misinterpretations. For example, in 
the questions about the drug lidocaine, it was its intravenous use we wanted to inquire about, 
but this was not specified, and the question could therefore be interpreted as regarding its use 
as a local anesthetic. This can affect the validity of the question, and must be considered when 
analyzing the responses. 
  
In the survey, terms such as tachycardia and hypotension were deliberately not used, as these 
commonly have fixed numerical definitions, not necessarily reached during general 
anesthesia. Too high or too low were used to more easily let the respondents define and 
determine the risks of blood pressure and heart rate levels, as these usually differ between 
patients.  
 
For specific statements regarding opioid-free anesthesia, a sixth response option was 
included: I don’t know, as not to force respondents to express an opinion on statements they 
may not have knowledge about. Omissions, I don’t know and neutral responses were analyzed 
separately, since they represent different attitudes in the study population (Stocké, 2006). The 
I don’t know-response option was used extensively in the Swedish version of the survey, and 
its inclusion is believed to have increased the validity of the results (Trost & Hultåker, 2016). 
Generalizability 
The survey was distributed to two Swedish anesthesia clinics that have been conducting pilot 
studies on opioid-free anesthesia. This may have caused selection bias in the Swedish results, 
decreasing the generalizability towards the target population of Swedish nurse anesthetists 
(Polit & Beck, 2012). Of the recruited sample in Sweden (318 nurse anesthetists), 51 nurse 
anesthetists were practicing at these two clinics, thus constituting 16% of the sample. Due to 
the anonymity of the survey, it is not possible to discern the response rate of these two clinics 
with opioid-free anesthesia pilot studies. They may therefore constitute a larger proportion of 
the analyzed responses. To increase the generalizability of the results, larger sample sizes and 
further research is required in both nations (Polit & Beck, 2012). 
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Result discussion 
When comparing the results between the United States and Sweden, the American 
respondents had more experience with opioid-free anesthesia. The majority of the American 
respondents agreed to all the benefits and disagreed to all the risks of opioid-free anesthesia 
listed in the survey questions. In the questions regarding benefits, risks and which drugs 
should be included in an opioid-free anesthesia regime of care, many of the Swedish 
respondents chose the alternative I don’t know. Respondents from both nations stated that 
opioid addiction was a major problem in society. 
Familiarity with opioid-free anesthesia 
Swedish and American nurse anesthetists reported considerably different familiarity with the 
concept of opioid-free anesthesia. Almost all the American respondents reported being 
familiar with the concept (figure 2), and more than half of the respondents clinically practiced 
opioid-free anesthesia at least once a week (figure 3). The situation was reported quite 
differently in Sweden, with only less than half of the respondents being familiar with the 
concept, and almost no one practicing opioid-free anesthesia every week. Hypothetically, the 
opioid epidemic in the United States may be a contributing factor to this difference, as it may 
lead to a higher general awareness of the negative and potentially lethal side effects of opioids 
(Koepke et al., 2018). The opioid epidemic is also commonly referenced in scientific articles 
on opioid-free anesthesia (Forget & Cata, 2017; Koepke et al., 2018; Kremer & Griffis, 2018; 
Mauermann et al., 2017).  
 
72% of the American respondents, and only 17% of the Swedish respondents, reported having 
read scientific articles about opioid-free anesthesia. In contrast to 24% of the Swedish nurse 
anesthetists reporting having clinically practiced opioid-free anesthesia, 17% is a worryingly 
low number. Considering the requirements of evidence-based practice and continuous 
education, stipulated in the description of competence for the nurse anesthetist, the reading of 
scientific articles should be an integral part of the nursing profession (Rf AnIva & SSF, 
2012). This is also reflected in the survey question about whether the evidence supports the 
use of opioid-free anesthesia, where the majority of the Swedish respondents chose the 
alternative I don’t know (figure 4). This may be evidence of a cultural or educational 
difference in the nurse anesthetist profession, regarding the acquisition of evidence-based 
knowledge, between the two nations. While the American nurse anesthetists may see it as 
their personal responsibility to seek and read current scientific articles, the Swedish nurse 
anesthetists may rely more on oral information from colleagues and the traditions and 
experiences of the clinic. As recertification is required in the United States, but not in 
Sweden, American nurse anesthetists may be more inclined to continuously pursue evidence-
based knowledge. 
 
Several of the articles referenced in this study were written by American researchers, and 
several RCTs have been conducted in American clinics (Brandal et al., 2017; Koepke et al., 
2018; Kremer & Griffis, 2018; Ziemann-Gimmel, Goldfarb, Koppman, & Marema, 2014). 
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However, the majority of the referenced articles have been from Europe, and it may only be a 
matter of time before the concept of opioid-free anesthesia is widely adopted in Sweden. 
There have been pilot studies in Sweden assessing the possibility of developing opioid-free 
anesthesia regimes of care. At one clinic in central Sweden, opioid-free anesthesia is being 
practiced as routine. 
Benefits 
Figure 11 in appendix 5 shows that the majority of the respondents in the United States agreed 
that opioid-free anesthesia has benefits for all the categories in the statement, compared to 
traditional opioid-based anesthesia. For example, benefits regarding the risk of PONV was 
one of the categories with the most agreements. PONV is a well-known problem related to 
anesthesia and has been prevalent since the introduction of ether. It is more common when 
opioids are included in anesthesia (Kremer & Griffis, 2018). Our findings are consistent with 
the evidence presented in the RCTs by Bakan et al. (2015) and Ziemann-Gimmel et al. 
(2014), who all found that opioid-free anesthesia lowered the incidence of PONV and the use 
of antiemetic rescue drugs. Today, the most widely used method of identifying patients at risk 
for developing PONV is the Apfel score. The four variables included in the Apfel score are 
gender, smoking, history of motion sickness or PONV and the use of postoperative opioids 
(Apfel et al., 1999). Moreover, the Apfel score was validated through the use of opioids as 
part of the anesthesia. If opioids are excluded from anesthesia, would the Apfel score still be 
valid as a predictor for PONV? This is unclear, as new evidence-based practice may be 
needed to validate alternate PONV-risk assessment tools for use with opioid-free anesthesia. 
However, an ongoing RCT comparing opioid-free versus opioid-based anesthesia, specifically 
looking at postoperative opioid related side effects, is still using the Apfel score to assess and 
prevent PONV (Beloeil et al., 2018). 
 
One of the categories of benefits was patients’ desires. This category generated one of the 
smallest amounts of agreements from the United States, though still a majority (appendix 5, 
figure 11). We can only speculate as to the reasoning behind the respondents’ answers, but 
one explanation may be that the nurse anesthetists regard some patients’ preoperative wishes 
to not receive opioids as a valuable reason to administer opioid-free anesthesia. With the 
spread of the opioid epidemic, and society becoming more aware of the negative effects of 
opioids, a growing proportion of patients may actively request opioid-free anesthesia in the 
future. 
  
The last question in the survey summarized what the nurse anesthetists perceived as important 
to avoid in all anesthesia practice, thereby identifying their priorities in the perioperative 
patient care, which correspond to the Code of Ethics of the International Council of Nurses 
(Rf AnIva & SSF, 2012). When comparing the Swedish responses to this question with the 
American responses to the question about the benefits of opioid-free anesthesia, similar 
patterns can be seen. First, the majority of all respondents agreed to all the categories. The 
categories regarding PONV, urinary retention and constipation were the categories with the 
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highest congruence between answers. For example, the American respondents regarded 
reduced PONV as one of the clearest benefits of opioid-free anesthesia compared to opioid-
based anesthesia, while the Swedish respondents all agreed that PONV was important to 
avoid. A conclusion could be that the experience of the American nurse anesthetists suggests 
opioid-free anesthesia would be beneficial to the priorities of the Swedish nurse anesthetists. 
Risks 
The majority of the respondents from the United States disagreed to the statements that 
opioid-free anesthesia has any of the intraoperative risks listed in the survey (figure 5). 
However, some of the respondents also agreed to the risks. The risks of the patient having 
heart rate and blood pressure: too high were perceived as the two greatest risks (20%, 14%), 
while heart rate and blood pressure: too low were the least perceived risks (2%, 3%), 
compared to traditional opioid-based anesthesia. In the RCT by (Bakan et al., 2015), the 
opioid-free anesthesia group had significantly higher blood pressure and heart rate during 
anesthesia than the control group. The opioid-free anesthesia was delivered using 
dexmedetomidine, lidocaine and propofol. This is consistent with our findings about the 
American nurse anesthetists’ perception of risks during opioid-free anesthesia, although it 
must still be considered that the majority of the respondents did not perceive too high blood 
pressure and heart rate as risks. Consequently, blood pressure and heart rate may be higher 
during opioid-free anesthesia, while not necessarily becoming too high. 
 
The risks regarding blood pressure and heart rate can also be related to another question in the 
survey, namely the one inquiring about which drugs to be included in an opioid-free 
anesthesia regime of care. Among the responses from American nurse anesthetists (appendix 
5, figure 13), ketamine was one of the most popular drugs to include in opioid-free anesthesia 
(95%). Ketamine is known to induce both tachycardia and hypertension. Conversely, 
clonidine was one of the least popular drugs to include (61%), and bradycardia and 
hypotension are some of its side effects (Bekhit, Navab, Ghobrial, & Aust, 2015). This may 
partially explain our findings. Another explanation could be that some respondents relate the 
omission of opioids from anesthesia to an increased nociceptive (“pain”) response in the 
patient during surgery, compared to traditional opioid-based anesthesia. Increased nociceptive 
response would imply inadequate analgesia and in turn cause higher blood pressure and heart 
rate (Cividjian et al., 2017; Forget, 2019). Other drugs that affect the hemodynamics are 
magnesium, which lowers heart rate but not blood pressure, dexmedetomidine, which lowers 
both heart rate and blood pressure, and propofol, which lowers blood pressure through 
vasodilation (Bekhit et al., 2015; Forget & Cata, 2017; Hirsch, Fox, & Kaye, 2015). 
  
The risk with the most disagreement was delay of spontaneous breathing. This can probably 
be explained by the avoidance of the otherwise common side effect of opioid-induced 
respiratory depression (Kremer & Griffis, 2018). 
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Drugs in the opioid-free anesthesia regime of care 
An interesting comparison can be made between figures 13 and 16 in appendix 5. Figure 13 
shows which drugs the American respondents think should be included in opioid-free 
anesthesia, and figure 16 shows the Swedish respondents’ familiarity with the same drugs. 
Three of the drugs identified by the American respondents as popular to include in an opioid-
free anesthesia regime of care were not very familiar to the Swedish respondents. These were 
magnesium, dexmedetomidine and lidocaine, which can all be used as adjuvants or substitutes 
for opioids during anesthesia (Kremer & Griffis, 2018; Mauermann et al., 2017). If the 
concept of opioid-free anesthesia is to be widely implemented in Sweden, more education 
about these drugs may be needed. As the nurse anesthetists are responsible for all the drugs 
they administer during anesthesia, including a dose assessment, extensive knowledge is 
needed about the pharmacodynamic effects of these non-opioid drugs (HSLF-FS 2017:37). 
Evidence-based practice should seek to understand the best combinations of non-opioid drugs 
and validate them for wide implementation of opioid-free anesthesia regimes of care 
(Johansson & Wallin, 2013; Walker & Avant, 2019). 
Measuring the depth of anesthesia 
The Swedish and American respondents had a completely different opinion on the importance 
of measuring depth of anesthesia during general anesthetics: more than two-thirds of the 
Swedish respondents answered yes to the question, while more than two-thirds of the 
American respondents answered no (figure 6). However, a higher percentage of the American 
respondents thought it was important to measure depth of anesthesia during opioid-free 
anesthesia, than in all general anesthetics, although the questions are not mutually exclusive 
(figure 7). Interestingly, the highest percentage of I don’t know-answers from the American 
respondents regarded measuring depth of anesthesia in opioid-free anesthesia (11%). 
Compared to the percentages of Swedish I don’t know-answers on many of the survey 
questions, this was not notably high, but isolated it showed the highest amount of uncertainty 
from the American respondents. Ketamine, one of the most popular drugs to be included in an 
opioid-free anesthesia regime of care (appendix 5, figure 13), is known to make BIS-
monitoring less accurate because it targets NMDA receptors instead of GABAA (Rani & 
Harsoor, 2012). This could explain the increased American uncertainty about depth of 
anesthesia monitoring in opioid-free anesthesia. To be able to measure depth of anesthesia, in 
order to ensure adequate hypnosis and analgesia, new methods need to be developed and 
tested for opioid-free anesthesia using evidence-based practice. Guedel’s classification of 
ether anesthesia, as well as the PRST-score, already less relevant today than at their 
introduction, may be rendered even more obsolete with the rise of opioid-free alternatives. As 
heart rate, blood pressure and cerebral neurotransmitters are affected differently by different 
non-opioid drugs, a complex multiparameter approach may be needed, combining 
measurements such as heart rate and blood pressure variation, EEG and skin conductance 
(Lavand’homme & Estebe, 2018). On the other hand, these questions can also be related to 
the question about risks of opioid-free anesthesia compared to traditional opioid-based 
anesthesia, where awareness was one of the risks with the most disagreement from American 
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respondents, consequently meaning it was perceived as an uncommon risk in opioid-free 
anesthesia (figure 5). 
Opioid addiction 
Opioid overdose is the leading cause of accidental death in the United States, and the 
government calls this opioid epidemic a national health emergency (Koepke et al., 2018; 
Kremer & Griffis, 2018). This was reflected in the present study, with more than 90% of the 
American respondents agreeing to the statement that opioid addiction is a major problem in 
society (figure 8). The Swedish respondents were generally less inclined to agree with the 
same statement. Not only was the aggregated agreement (agree + strongly agree) smaller, but 
also the intensity of the agreement differed largely from the American respondents: Only 27% 
of the Swedish respondents strongly agreed to the statement, versus 72% of the American 
respondents. This may partially be explained by the fact that, at least when looking at opioid 
prescription, no “epidemic” is seen in Sweden, as the prescription of opioids has been 
relatively constant during the last 10 years (Bäckryd, Heilig, & Hoffmann, 2017-05-03). 
However, the American opioid epidemic encompasses more than prescription drugs. 
Therefore, looking solely at prescription of opioids may not be enough to fully assess the 
situation, and statistics such as opioid overdose as cause of death should also be included. 
Looking at numbers from 2017, death from opioid overdose was 2.4 times as common in the 
United States than in Sweden, although the scope of the problem is growing in both nations 
(National Institute on Drug Abuse, 2019; Public Health Agency of Sweden, 2019). 
 
Opioid-free anesthesia does not always lead to a totally opioid-free postoperative care. As 
described by Brandal et al. (2017), patients were prescribed opioids at discharge 
independently of patient assessed pain score and postoperative opioid consumption. This 
means that the attitude of the nurse anesthetist may also have a role in the extent of the use of 
opioids. An attempt to measure the attitudes of the nurse anesthetists towards opioids was 
made in the present study, by asking the questions presented in figures 8, 9 and 10. Although 
a majority of the American respondents believed that administering opioids intraoperatively 
can lead to opioid dependence, the answers were widely spread across the Likert scale (figure 
10). In Sweden, the respondents were more inclined to disagree with the statement.  
 
Although we have not found definitive evidence in scientific articles supporting the statement 
that administering opioids intraoperatively can lead to opioid dependence, a connection can 
be observed. Patients receiving high doses of remifentanil intraoperatively have a high risk of 
developing opioid-induced hyperalgesia, leading to increased postoperative pain and opioid 
consumption (Santonocito et al., 2018), thus increasing the risk of dependence (Brandal et al., 
2017). Koepke et al. (2018) describe several studies where postoperative opioid dependence 
was developed in between 6% and 10% of patients after opioid-based anesthesia. A dose-
dependent connection between intraoperative opioids and readmission to a hospital after 
anesthesia has also been observed (Long et al., 2018). We therefore consider that it may be 
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possible to conclude that administering opioids intraoperatively can lead to opioid 
dependence, although more evidence is needed to be certain. 
Experiences of the investigators 
The investigators participated in a two-week Student Exchange Program with the University 
of North Florida in the United States. The main purpose of the exchange program was to 
collect data for this study. We also visited a hospital in North Florida, where we observed 
local anesthesia practice. Although we did not have the opportunity to observe a patient under 
opioid-free anesthesia, most of the nurse anesthetist we met spoke highly of the concept. We 
made the observation that American nurse anesthetists generally used a more multimodal 
approach to anesthesia than we were accustomed to from our Swedish clinical placements. 
Drugs commonly used included midazolam, propofol, fentanyl, ketamine, lidocaine and 
dexmedetomidine. 
Summary and clinical implications 
Familiarity with opioid-free anesthesia was a lot more common in the United States than in 
Sweden (figures 2 and 3). Currently, only two Swedish anesthesia clinics administer opioid-
free anesthesia and the knowledge of the concept is limited. This means that people who 
would benefit from opioid-free anesthesia, for reasons such as high risk of PONV or history 
of opioid abuse (figure 9 and appendix 5, figure 11), are less likely to avoid opioids during 
anesthesia in Sweden. Consequently, the Swedish healthcare system struggles with the 
negative effects of opioids in the postoperative patient care. Remifentanil, one of the most 
common intraoperative opioids used in Swedish anesthesia practice, causes hyperalgesia and 
increased postoperative opioid consumption (Santonocito et al., 2018). Ultimately, this may 
lead to increased opioid dependence, addiction and overdose in society, similarly to the opioid 
epidemic endured in the United States. With consequences of longer hospital stays and human 
suffering, both the economic and social sustainability of increased opioid consumption can be 
thoroughly questioned. 
 
As awareness of the American opioid epidemic increases internationally, measures to prevent 
opioid consumption may be taken. Soon, patients may start to request opioid-free anesthesia, 
and Swedish healthcare practitioners need to prepare for the new paradigm by seeking 
evidence-based knowledge about the concept. Familiarity with non-opioid analgesics must be 
acquired for administration of safe anesthesia. Further understanding about the complexity of 
nociception during anesthesia may also be needed, to shift focus from relieving “pain“ with 
opioids, to other methods of suppressing the sympathetic response of surgical stimuli. 
 
If, or when, opioid-free anesthesia becomes the norm, current methods of risk assessment and 
depth of anesthesia monitoring may become unreliable. Opioid-free anesthesia is a relatively 
new concept, and as an inexperienced practitioner, finding the right depth of anesthesia with a 
new combination of drugs may prove difficult. More research on opioid-free anesthesia, 
combinations and doses of non-opioid analgesics is needed, and RCTs should be 
systematically compiled in meta-analyses to determine the best available evidence-based 
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practice. In addition, the nursing perspective of opioid-free anesthesia should be researched 
using both qualitative and quantitative methods. 
 
Conclusion 
By having constructed, distributed and analyzed the responses of two web-based surveys, we 
have compared experiences of opioid-free anesthesia among nurse anesthetists in Sweden and 
the United States. We conclude that American nurse anesthetists have more clinical 
experience and theoretical knowledge of opioid-free anesthesia compared to Swedish nurse 
anesthetists. American nurse anesthetists experience many benefits of opioid-free anesthesia 
compared to traditional opioid-based anesthesia, while not experiencing many risks. Swedish 
nurse anesthetists have limited experience with opioid-free anesthesia, and are unsure about 
its risks and benefits. More education about non-opioid analgesics is needed for a safe 
implementation of the concept in Sweden. Nurse anesthetists in both nations think opioid 
addiction is a major problem in society, but American nurse anesthetists are more inclined to 
connect this problem to intraoperative opioids.  
 
Our findings can be used to educate Swedish nurse anesthetists about opioid-free anesthesia, 
while hopefully stimulating further reading of evidence-based knowledge about the concept. 
We have also shown that the American nurse anesthetists’ experiences with the benefits of 
opioid-free anesthesia correspond with the Swedish nurse anesthetists’ priorities in all 
perioperative patient care. This suggests that opioid-free anesthesia would be beneficial to 
postoperative patient outcome, if implemented widely in Sweden. 
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Appendix 3: Information to the research participants 
Forskningspersonsinformation –  
Opioidfri anestesi i Sverige och USA 
 
Bakgrund 
Denna studie avser att jämföra svenska och amerikanska anestesisjuksköterskors upplevelser 
och erfarenheter av opioidfri anestesi. Studien utförs av två studenter på 
specialistsjuksköterskeprogrammet med inriktning mot anestesisjukvård vid Göteborgs 
universitet.  
 
Förfrågan om deltagande 
Du är inbjuden att delta i den här studien för att du arbetar som anestesisjuksköterska i 
Sverige eller i USA, eller för att du studerar till anestesisjuksköterska. Vi är intresserade av 
dina erfarenheter av opioidfri anestesi (OFA). Att delta i studien är frivilligt. Valet att inte 
delta kommer inte att leda till några negativa följder. Enkäten har skickats ut per email från 
våra kontaktpersoner; Dr. John McDonough, University of North Florida och Dr. Pether 
Jildenstål, Göteborgs universitet. Forskningshuvudman för projektet är Göteborgs universitet.  
 
Hur går studien till? 
Som forskningsperson kommer du att få svara på en elektronisk enkät. En länk till enkäten 
kommer skickas till din e-post. Enkäten består av 20 flervalsfrågor där du har möjligheten att 
bedöma din erfarenhet och upplevelse på skalor. Att besvara enkäten tar ca 5-10 minuter. 
 
Resultatet kommer att analyseras statistiskt genom att jämföra svar från Sverige och USA. 
Enkäterna innehåller samma frågor, endast översatta till svenska eller engelska. 
 
Fördelar och risker med deltagande 
Denna studie kommer inte att ge några direkta fördelar för dig, men förhoppningen är att 
erfarenhet av opioidfri anestesi i Sverige och USA kommer kunna jämföras, spridas och 
utbytas mellan anestesisjuksköterskor i båda länder. Om någon fråga får dig att känna dig 
obekväm kan du lämna frågan obesvarad. 
 
Hantering av data och sekretess 
Endast de svar som du själv väljer att lämna in kommer att registreras. All data kommer att 
redovisas på gruppnivå och avidentifieras. Enkäten är anonym och dina svar kommer inte att 
kunna härledas till dig. Information om vem som har svarat på enkäten registreras ej. Dina 
svar kommer att behandlas så att inte obehöriga kan ta del av dem. Ansvarig för dina 
personuppgifter är Göteborgs Universitet. Dataskyddsombud: Kristina Ullgren 
(dataskydd@gu.se). 
 
Hur fås information om studiens resultat? 
Svarsdata som samlas in kommer att användas i en Magisteruppsats som skrivs i 
Specialistsjuksköterskeprogrammet med inriktning mot anestesisjukvård vid Göteborgs 
universitet. Uppsatsen kommer att publiceras i GUPEA, Göteborgs universitets elektroniska 
arkiv (gupea.ub.gu.se) och kan fritt laddas ner där. Uppsatsen kan bli publicerad i en 
  
vetenskaplig tidskrift. Du kan också kontakta de huvudansvariga forskarna för att få en 
elektronisk kopia. 
 
Försäkring och ersättning  
Studien är inte kopplad till något försäkringsskydd. Ersättning för deltagande utgår ej. Du 
förväntas inte få några utgifter eller förlorad inkomst på grund av ditt deltagande. 
 
Frivillighet 
Att delta i studien är frivilligt. Genom att besvara enkäten och trycka på skicka samtycker du 
till att delta i studien. Du har rätt att när som helst under besvarandet av enkäten ångra dig och 
avbryta studien utan att ge någon motivering. De forskningsdata som du har bidragit med 
kommer då att uteslutas och all svarsdata kommer att raderas. 
 
Kontaktinformation 
Huvudansvariga forskare är: 
Daniel Verbeeck, BSN, leg. sjuksköterska. E-post: gusverbda@student.gu.se 
Sofia Pihlblad, BSN, leg. sjuksköterska. E-post: guspihlb@student.gu.se 
 
Kontakt på University of North Florida: 
Dr. John P. McDonough 
CRNA, EdD, Dr.(habil)NScA, APRN, FRSM 
Professor & Director, Nurse Anesthesiology Program 
 
Forskningshuvudman samt personuppgiftsansvarig för studien är Göteborgs Universitet. 
Pether Jildenstål 
Programansvarig specialistsjuksköterskeutbildningen, 
Universitetslektor, Docent, Medicine doktor 
Översjuksköterska i anestesi, an/op/iva kliniken, område 5, SU, Göteborg 
Institutionen för vårdvetenskap och hälsa  
Sahlgrenska akademin vid Göteborgs Universitet 
Arvid Wallgrensbacke  
Box 457 
405 30 Göteborg, besöksadress 413 46, Göteborg 
Tfn: +46317866044 
E-post: pether.jildenstal@gu.se 
 
 
 
  
  
Appendix 4: Non-opioid drugs 
Ketamine 
Ketamine is an NMDA receptor antagonist with analgesic, anti-hyperalgesic, anesthetic and 
sedative effects. By depressing activity in the cortex and simultaneously stimulating the 
limbic system, ketamine creates so-called dissociative anesthesia. This is associated with 
vivid dreams and hallucinations. Ketamine can also be used to treat acute pain, treat and 
prevent chronic pain, while even small doses significantly reduce opioid need. Some side 
effects are related to increased epinephrine and norepinephrine circulation, leading to 
tachycardia and hypertension, while other side effects include increased intracerebral 
pressure, salivation and muscle tone, and bronchial dilatation (Bekhit et al., 2015). In a meta-
analysis hypothesizing that ketamine provides better hemodynamic control than placebo, 
ketamine was found to have a significantly reduced effect on blood pressure variability, but 
no such effect on heart rate (Forget & Cata, 2017). 
 
Lidocaine 
Lidocaine is an amino amide that is used as a local anesthetic, blocking sodium channels and 
thereby inhibiting the neural action potential (Bekhit et al., 2015). However, it can also be 
used intravenously for a number of purposes. It was initially used intravenously for its 
antiarrhythmic properties, but it also has analgesic, anti-hyperalgesic, anti-inflammatory, anti-
microbial and anti-tumoral effects, as well as preventing bronchoconstriction and 
postoperative ileus. Even intravenously, at recommended doses, therapeutic index is high and 
concentration stays well below toxic levels (Beaussier, Delbos, Maurice-Szamburski, 
Ecoffey, & Mercadal, 2018). 
 
Propofol 
Propofol is one of our most common intravenous induction drugs. Propofol is prepared in a 
fat emulsion and similarly to barbiturates binds to the GABAA receptor. Negative inotropy 
and peripheral vasodilatation commonly occurs during induction with profound decreases in 
blood pressure (Hirsch et al., 2015). 
 
Alpha 2-agonists 
The drugs clonidine and dexmedetomidine are both alpha 2-agonists that can be used as 
adjuvants for analgesic purposes. They work through stimulating alpha 2-receptors, which 
leads to decreased release of norepinephrine peripherally and in the CNS. The effect is both 
analgesic and sedative, without causing respiratory depression. The drugs can be used to 
reduce both opioid consumption and the incidence of nausea. Side effects can be bradycardia 
and hypotension (Bekhit et al., 2015; Santonocito et al., 2018). 
  
  
Magnesium 
Magnesium sulfate is used as an antiarrhythmic drug which affects the myocardial cells. It 
also has an analgesic effect, likely explained by its ability to block NMDA-receptors. 
Magnesium can be used as a compliment to the anesthesia regime intravenously, intrathecally, 
epidurally or through skin infiltration. In clinical trials, intravenous magnesium reduced the 
need for opioids by as much as 24%. Magnesium lowers the heart rate, but not the blood 
pressure. At high serum levels, side effects include neuromuscular blockade, skeletal muscle 
weakness, lethargy, nausea, vomiting and electrocardiogram changes (Bekhit et al., 2015). In 
a meta-analysis, magnesium was found to stabilize heart rate. Magnesium can be used as an 
adjuvant analgesic in opioid-free anesthesia, and also maintains hemodynamic stability when 
used in combination with ketamine (Forget & Cata, 2017). 
 
COX-inhibitors 
Ketorolac (Toradol®) and ibuprofen are nonsteroidal anti-inflammatory drugs (NSAIDs), also 
known as COX-inhibitors. Inhibition of COX-2 has analgesic effects, while inhibition of 
COX-1 inhibits platelet aggregation and prostaglandin synthesis in the gastric mucosa. Both 
ketorolac and ibuprofen are non-selective COX-inhibitors, meaning they affect both COX-1 
and COX-2 (Bekhit et al., 2015). These drugs are mainly administered intraoperatively to 
reduce postoperative pain. 
 
Acetaminophen / Paracetamol 
Paracetamol has both analgesic and antipyretic effects and can be used as a basis for 
postoperative analgesia. The exact pharmacodynamic mechanism is not known, it is believed 
to involve both peripheral and central effects. Paracetamol is metabolized in the liver and 
overdoses can cause irreversible hepatic injury. However, within therapeutic doses, 
paracetamol has no side effects and is also suitable for pregnant women and children (FASS, 
2018a). 
 
Nitrous oxide (N2O) 
Nitrous oxide causes sleep and analgesia. It is the oldest anesthetic agent still in use, 
discovered in 1772. Nitrous oxide has a high MAC-value, meaning it can only be used as a 
complementary anesthetic, though it has an additive and potentiating effect on other 
anesthetic gases leading to a dose reduction. It is excellent to use during induction, as it 
causes negligible respiratory depression and is nearly odorless in concert with being 
hemodynamically stable. Nitrous oxide diffuses into air-filled cavities in the body, such as the 
middle ear, sinuses and gas filled bowels as well as the cuff of an endotracheal tube. Hence it 
is contraindicated for ileus, open eye or skull trauma, pneumothorax and surgery in the middle 
ear (Frost, 2015; Ko, Kaye, & Urman, 2015). 
 
  
  
Appendix 5: Charts 
 
 Figure 11. Benefits of opioid-free anesthesia according to American nurse anesthetists. (n= see figure) 
 
 Figure 12. Benefits of opioid-free anesthesia according to Swedish nurse anesthetists. (n= see figure) 
  
 
Figure 13. Drugs to be included in an opioid-free anesthesia regime of care. Answers from the United States. 
(n= see figure) 
 
Figure 14. Drugs to be included in an opioid-free anesthesia regime of care. Answers from Sweden. (n= see 
figure) 
  
 
 Figure 15. Self-reported familiarity with non-opioid drugs. Answers from the United States. (n=see figure) 
 
 Figure 16. Self-reported familiarity with non-opioid drugs. Answers from Sweden. (n=see figure) 
 
 
 
  
  
 
Figure 17. When depth of anesthesia is measured. “If you answered ‘yes’ to ‘Do you think it is important to 
measure depth of anesthesia in all general anesthetics?’ do you do it” (Sweden n=49, United States n=62; 
GA=general anesthesia, MR=muscle relaxants.)  
  
 
 Figure 18. Important to avoid in all anesthesia according to American nurse anesthetists. (n=see figure) 
 
 Figure 19. Important to avoid in all anesthesia according to Swedish nurse anesthetists. (n=60) 
